Cognition Therapeutics | 8-K: FY2026 Q2 Revenue: USD 0
I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2026 Q2, the actual value is USD 0.
EPS: As of FY2026 Q2, the actual value is USD -0.04.
EBIT: As of FY2026 Q2, the actual value is USD -3.929 M.
The provided reference, a Form 8-K filing by Cognition Therapeutics, Inc., states that actual financial and operational metrics, cash flow data, unique metrics, or any forward-looking outlook/guidance are not contained within this specific document. These details are indicated to be furnished as Exhibit 99.1, which is not part of the text provided for analysis. Therefore, no financial or operational metrics can be extracted from the given reference.